Medical Journals

Foxp3 Controls Regulatory T-cell Function by Interacting with Aml1/Runx1.

Authors:
  • Ono Masahiro
  • Yaguchi Hiroko
  • Ohkura Naganari
  • Kitabayashi Issay
  • Nagamura Yuko
  • Nomura Takashi
  • Miyachi Yoshiki
  • Tsukada Toshihiko
  • Sakaguchi Shimon

From: Department of Experimental Pathology, Institute for Frontier Medical Sciences, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.

Nature

  • Publish Date: Apr 2007
  • ISSN: 1476-4687
  • Volume: 446
  • Issue: 7136
  • Pages: 685-9
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Ono Masahiro, Yaguchi Hiroko, Ohkura Naganari, et al. Foxp3 Controls Regulatory T-cell Function by Interacting with Aml1/Runx1.. Nature Apr 2007;446:685-9

Abstract

Naturally arising CD25+CD4+ regulatory T cells (T(R) cells) are engaged in the maintenance of immunological self-tolerance and immune homeostasis by suppressing aberrant or excessive immune responses, such as autoimmune disease and allergy. T(R) cells specifically express the transcription factor Foxp3, a key regulator of T(R)-cell development and function. Ectopic expression of Foxp3 in conventional T cells is indeed sufficient to confer suppressive activity, repress the production of cytokines such as interleukin-2 (IL-2) and interferon-gamma (IFN-gamma), and upregulate T(R)-cell-associated molecules such as CD25, cytotoxic T-lymphocyte-associated antigen-4, and glucocorticoid-induced TNF-receptor-family-related protein. However, the method by which Foxp3 controls these molecular events has yet to be explained. Here we show that the transcription factor AML1 (acute myeloid leukaemia 1)/Runx1 (Runt-related transcription factor 1), which is crucially required for normal haematopoiesis including thymic T-cell development, activates IL-2 and IFN-gamma gene expression in conventional CD4+ T cells through binding to their respective promoters. In natural T(R) cells, Foxp3 interacts physically with AML1. Several lines of evidence support a model in which the interaction suppresses IL-2 and IFN-gamma production, upregulates T(R)-cell-associated molecules, and exerts suppressive activity. This transcriptional control of T(R)-cell function by an interaction between Foxp3 and AML1 can be exploited to control physiological and pathological T-cell-mediated immune responses.

Mesh Headings (Keywords): Animals, Core Binding Factor Alpha 2 Subunit, Forkhead Transcription Factors, Gene Expression Regulation, Humans, Interleukin-2, Lymphocyte Activation, Mice, Phenotype, Promoter Regions (Genetics), Protein Binding, T-Lymphocytes, Regulatory


Check for Full Text / PubMed Unique Identifier (PMID): 17377532


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.